Financial reports
10-K
2023 FY
Annual report
20 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
24 Mar 22
10-Q
2021 Q3
Quarterly report
16 Dec 21
Current reports
8-K
Departure of Directors or Certain Officers
5 Feb 24
8-K
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
26 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
11 Jul 23
8-K
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
8 Jun 23
8-K
Other Events
23 May 23
8-K
Entry into a Material Definitive Agreement
5 May 23
8-K
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
3 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Entry into a Material Definitive Agreement
8 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
13 Jul 23
424B2
Prospectus for primary offering
4 May 23
424B2
Prospectus for primary offering
21 Apr 23
S-1/A
IPO registration (amended)
17 Apr 23
S-1/A
IPO registration (amended)
10 Apr 23
424B2
Prospectus for primary offering
9 Mar 23
S-1
IPO registration
10 Feb 23
S-3
Shelf registration
1 Feb 23
DRS/A
Draft registration statement (amended)
30 Nov 22
DRS
Draft registration statement
14 Oct 22
Proxies
PRE 14A
Preliminary proxy
19 Apr 24
DEF 14A
Definitive proxy
26 May 23
PRE 14A
Preliminary proxy
16 May 23
DEF 14A
Definitive proxy
11 Oct 22
PRE 14A
Preliminary proxy
28 Sep 22
DEF 14A
Definitive proxy
2 May 22
PRE 14A
Preliminary proxy
22 Apr 22
Other
EFFECT
Notice of effectiveness
21 Apr 23
EFFECT
Notice of effectiveness
13 Feb 23
UPLOAD
Letter from SEC
9 Feb 23
CORRESP
Correspondence with SEC
8 Feb 23
CERT
Certification of approval for exchange listing
12 Nov 21
EFFECT
Notice of effectiveness
12 Nov 21
CORRESP
Correspondence with SEC
8 Nov 21
CORRESP
Correspondence with SEC
8 Nov 21
CORRESP
Correspondence with SEC
19 Oct 21
CORRESP
Correspondence with SEC
12 Oct 21
Ownership
SC 13D
STROME MARK E
25 Oct 23
4
Urioste George de
3 Oct 23
4
Urioste George de
29 Sep 23
4
Urioste George de
27 Sep 23
4
Urioste George de
22 Sep 23
4
Urioste George de
19 Sep 23
4
Urioste George de
15 Sep 23
SC 13D
PUBLIC VENTURES, LLC
28 Aug 23
4
Kenneth Harry Persen
4 Aug 23
4
Branislav Vajdic
4 Aug 23